Malignant Vascular Neoplasm — Trials

Malignant Vascular Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

193 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 36
Recruiting: 22
Ph III recruiting: 0
Growth YoY: —
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (21)

clinicaltrialsPublishedShowing 1–14 of 14 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06898970	Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma	recruiting	Phase 2	18	Varun Monga, MBBSOTHER	1	Sep 1, 2026	clinicaltrials
NCT04941274	Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma	recruiting	Phase 1 / Phase 2	111	National Cancer Institute (NCI)NIH	1	Aug 25, 2026	clinicaltrials